Cervical Device Contraception-2 (Nanopaz)

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

UNKNOWN

Clinical Phase

PHASE1/PHASE2

Total Enrollment

10 participants

Study Classification

INTERVENTIONAL

Study Start Date

2008-06-30

Study Completion Date

2010-05-31

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

Measure blood progesterone by using cervical device contraception.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

A very small cervical device that releases small amount of progesterone 20 mcgm/day.

The target of the research is to measure blood progesterone by using the cervical device.

This small device delivers progesterone by nanotechnology method.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Healthy

Keywords

Explore important study keywords that can help with search, categorization, and topic discovery.

Nanopaz device Blood progesterone measure in using the device Delivery progesterone Progesterone levonorgestrel

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

NON_RANDOMIZED

Intervention Model

SINGLE_GROUP

Primary Study Purpose

PREVENTION

Blinding Strategy

NONE

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Nanopaz contraception device

levonorgestrel and levonorgestrel device for cervical contraception-nantechnolgy method

Intervention Type OTHER

Other Intervention Names

Discover alternative or legacy names that may be used to describe the listed interventions across different sources.

levonorgestrel device for cervical contraception-nantechnolgy method

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* 10 healthy women are candidate for hysterectomy

Exclusion Criteria

* Women with neoplastic malignancy disease or thrombophylia

Minimum Eligible Age

1 Month

Maximum Eligible Age

2 Months

Eligible Sex

FEMALE

Accepts Healthy Volunteers

Yes

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Bnai Zion MC

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

BnaiZionMC-08-BP-003-CTIL

Identifier Type: -

Identifier Source: org_study_id